Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by geodcanon Nov 27, 2022 7:44pm
209 Views
Post# 35132511

RE:chefboy and homeboy say canopy is a buy

RE:chefboy and homeboy say canopy is a buy
charliebitmyfin wrote:

3 Glaring Red Flags Canopy Growth Investors Can't Afford to Ignore

 

Motley Fool - Wed Nov 23, 7:35AM CST
 

Cannabis producer Canopy Growth (NASDAQ: CGC) has been focused on the U.S. market for multiple years now. In 2019, it announced plans to acquire Acreage Holdings, and since then, it has made similar deals with other companies.

But promises of long-term growth are nothing new for the cannabis industry. Investors interested in the industry need to be careful about getting caught up in the hype. And when it comes to Canopy Growth, there are some serious red flags investors should consider before taking a chance on the stock.

1. The company's focus on the U.S. market could be risky and costly

 

Canopy Growth has been expending resources on expansion into the U.S., but there's one huge problem: They can't operate in the market just yet. And while the launch of Canopy USA (where it will consolidate its U.S. investments) may have you convinced it's inevitable, in reality, it could still take many years for regulation to take place (assuming it does at all). Canopy Growth's aggressive plans to consolidate results from Canopy USA could also risk the company getting delisted from the Nasdaq.

Setting up Canopy USA is just one example of how the company spent resources where it may not have made plenty of sense to do so. Although it's not explicitly stated how much, the company is incurring costs on something that may not be all that beneficial for the business right now. Its wretched bottom line -- which was at a net loss of 231.9 million Canadian dollars in the second quarter (period ended Sept. 30) -- or nonexistent sales growth are areas that should be higher priorities right now.

2. Sales are disastrous in Canada

 

The company's net revenue for Q2 was CA$117.9 million and declined 10% year over year. But some of the worst numbers came from the Canadian market, where Canopy Growth's recreational sales crashed 35% to CA$38.1 million. Its business-to-business sales declined by 40%, while revenue from the business-to-consumer market fell by 23%.

Investors may be surprised to learn that two years ago, Canopy Growth's revenue from the Canadian recreational market totaled CA$60.9 million; it has declined by an incredible 37% over that time. Although Canopy Growth is looking to focus more on the U.S. market, by not growing and achieving strong results in Canada, it isn't putting itself in a good position for success if and when the opportunity to enter the U.S. market arises.

3. Its cash burn is worsening

 

To make matters worse, Canopy Growth is also burning through increasingly more cash. The cannabis company reported a free cash outflow of CA$135.4 million during Q2, which was 34% more than the amount it used in the prior-year period. The company does have more than CA$1.1 billion in cash and short-term investments that can help absorb the cash burn, but it's not sustainable in the long run.



Why I'd avoid Canopy Growth stock

Investors may be tempted to invest in Canopy Growth in the hopes that it will be a big winner when the U.S. legalizes marijuana, but that's by no means a sure thing. For the company to be in a good position to enter the U.S. and grow its business, it needs strong financials -- something it doesn't have today.

And investors also need to prepare for the worst-case scenario: that legalization doesn't take place for years. Its core Canadian operations don't look great, and with deep losses, plenty of cash burn, and sales dropping significantly, the business simply doesn't make for a good investment today.



Reasonable write with a whole lot of truth in it.  For myself, I am a big picture guy and their US intentions have been the focus all along imho.  

Canadian pot is a failure by design and very costly to our homegrown companies that are doing business in Canada, Thank You government!

I'm not willing to write Canopy off because they have hardcore businesspeople calling the shots and true to form are positioning themselves for doing business in the US and Acreage and all of the other interests are in the works, with very  creative, almost non-understandable deals written and paid for at bargain basement prices and they are still not happy but want to revisit the Acreage floating share deal one more time because it seemed too generous and they can still wak from the deal and go with their other investments to round themselves out and do pot business in the US

I bet plenty on Acreage becoming Canopy Growth USA division and whatever parts of their other investments that they need or want.

I am willing to put my money where my mouth is but didn't expect the momentous announcement of it being time for Canopy to test the resilience of the US politicians and potpreneurs.  That threw a screwing into my offer for 10k shares at a more reasonable shareprice.  For me, my offer is a double from my first investment into Canopy and I hate averaging up but stand behind my old posts of Canopy coming out highup on the list in the US.  I am one of those people that believe this will go back to the $70 range or higher and willing to plunk down for it, despite all of the creative deals that are going on in regards to our success or failure.

Soft market, wild card politics and tax loss selling could get my order filled.  Don't forget that US legalization will have those US investors that aren't shareholders of Canopy, lining up and that will make shares in short supply.  And Acreage is going to be able to swap their shares for Canopy shares.

At one time the whole deal was figured at $4.3 billion dollars but STZ locked it up for $38 million and some Canopy share dilution for the swapped out Acreage fixed and floating shares.  Shares are cheap to print and that is what I meant when I said STZ are hardcore businesspeople who saw Canopy as the best deal and put up 5 billion C to be a part of it.

glta and dyodd 




<< Previous
Bullboard Posts
Next >>